Related Experiment Video
Updated: Dec 24, 2025

10:33
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
11.0K
Dual stimuli-responsive saccharide core based nanocarrier for efficient Birc5-shRNA delivery
Huiying Chen1, Yu Ma, Haoming Lan
1Key Laboratory of Biotechnology and Bioresources Utilization, Ministry of Education, Dalian Minzu University, 18 Liaohe West Road, Jinzhou New District, Dalian, Liaoning Province 116600, P. R. China. zsb@dlnu.edu.cn.
Journal of Materials Chemistry. B
|April 8, 2020
Summary
This study introduces a novel dual stimuli-responsive nanocarrier for gene therapy. The new system demonstrates enhanced gene delivery and tumor inhibition with improved biocompatibility.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Gene Therapy
Background:
- Stimuli-responsive delivery systems are crucial for effective gene transfection.
- Existing systems face challenges in achieving optimal delivery and therapeutic outcomes.
- Need for advanced nanocarriers with enhanced gene condensation, circulation, and cellular uptake.
Purpose of the Study:
- To develop and evaluate a novel dual stimuli-responsive nanocarrier for gene therapy.
- To assess the efficacy of the nanocarrier in delivering Birc5-shRNA for tumor inhibition.
- To investigate the biocompatibility and safety of the developed nanocarrier system.
Main Methods:
- Construction of a dual stimuli-responsive chitosan (SCS) core using pH-sensitive hydrazone and redox-sensitive disulfide bonds.
- Immobilization of polyethyleneimine (PEI) and polyethylene glycol (PEG) onto the SCS core to form SCS-g-PEI-g-PEG.
- In vitro and in vivo evaluation of gene delivery efficiency, tumor inhibition, and toxicity.
Main Results:
- The SCS-g-PEI-g-PEG nanocarrier exhibited dual stimuli-responsive properties.
- Significantly enhanced Birc5-shRNA gene expression and tumor inhibition were observed compared to non-responsive controls.
- The nanocarrier demonstrated excellent biocompatibility in both in vitro and in vivo toxicity assessments.
Conclusions:
- The novel SCS-g-PEI-g-PEG nanocarrier is an efficient and biocompatible system for gene therapy.
- Dual stimuli-responsiveness enhances gene delivery and therapeutic efficacy.
- This strategy offers a promising approach for developing advanced gene delivery vectors.

